Recalls / Active ingredient / Methylprednisolone Acetate
Methylprednisolone Acetate
5 FDA drug recalls involving the active ingredient “Methylprednisolone Acetate”.
| Date | Class | Product | Firm |
|---|---|---|---|
| 2024-04-25 | Class II | MethylPREDNISolone Acetate Injectable Suspension, USP, 400 mg per 10 mL (40 mg per mL), 1 x 10 mL Multi-Dose V | Sagent Pharmaceuticals |
| 2024-02-20 | Class II | Methylprednisolone acetate Injectable Suspension, USP, 400mg per 5mL (80mg/mL, 5mL Multiple-Dose Vial, Rx only | Eugia US LLC |
| 2022-04-13 | Class II | Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 80mg/mL, packaged in a) 1 mL single-dose v | Mckesson Medical-Surgical Inc. Corporate Office |
| 2022-04-13 | Class II | Depo-Medrol (methylprednisolone acetate injectable suspension, USP) 40 mg/mL, 1 mL single-dose vial, Rx only, | Mckesson Medical-Surgical Inc. Corporate Office |
| 2014-07-30 | Class III | Depo-Medrol (methylprednisolone acetate injectable suspension USP), 40 mg/ mL, 1 mL Single-Dose Vial, Rx only, | Pfizer Inc. |